ADAMTS10, ADAMTS17, ADAMTSL4, CBS, FBN1
The CDL offers a 5 gene panel for genes associated with ectopia lentis. Pathogenic variants in ADAMTS10, ADAMTS17, ADAMTSL4, FBN1, and CBS have been identified in individuals with ectopia lentis. This panel is recommended for individuals with possible autosomal dominant or autosomal recessive ectopia lentis.
Ectopia lentis is the displacement of the eye’s crystalline lens, a clear structure at the front of the eye that focuses light. Vision problems are common in these individuals and may include nearsightedness (myopia), irregular curvature of the lens (astigmatism), clouding (cataracts), or increased pressure within the eyes (glaucoma). Ectopia lentis occurs in approximately 1 in 15,600 individuals and usually occurs as part of a broader, systemic condition such as Marfan Syndrome or Homocystinuria.
Next Generation Sequencing: Next generation DNA sequencing is performed to identify nucleotide variants in the coding portion of the genome. All nucleotides in the coding exons and their flanking splice junctions are sequenced to a read coverage of greater than 20X. The sequence data are assembled and compared to the published genomic reference sequence. Sanger sequencing is performed if necessary to ensure complete nucleotide coverage of the target sequence and to confirm all reported variants. Human Genome Variation Society (HGVS) recommendations are followed for variant nomenclature and ACMGG/AMP variant interpretation guidelines are followed to assess variant pathogenicity, unless otherwise indicated. The following online databases and in silico analysis tools are routinely used for variant investigation: ClinVar, NHLBI Exome Sequencing Project, 1000 Genomes, dbSNP, Exome Aggregation Consortium (ExAC), available loci specific variant databases, PolyPhen-2, SIFT, Provean, Mutation Taster and Human Splicing Finder.
BLOOD IS PREFERRED.
BLOOD: 2 EDTA (purple top) tubes
Whole blood may be stored up to 5-7 days in the refrigerator before shipping.
5 µg DNA at a minimum concentration of ≥200 ng/µl
Oragene Saliva samples are accepted
Blood samples (or DNA) should be well labeled with patient’s full name and an identifying number.
Ship sample at room temperature with overnight delivery.
Clinical information outlining the indication for the requested tests and pertinent medical history and family history is a necessary component of testing. Please include a clinic note when available.
CPT Code & Cost81479